Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The day is not over.. Risk and Reward.. IMHO
Could follow Lampert's play book? 38% up after filing for BK..
https://markets.businessinsider.com/news/stocks/sears-stock-price-nearly-doubles-day-after-bankruptcy-filing-2018-10-1027622853
Thought you would like it! Classic
Why no news today? I thought the deal was supposed to be finalized today. When is SGYP going to get its Q?
Hahaha the Scarecrow end up being the smartest out of the group...
That a National treasure...Good One
patience, grasshopper.
the company is bankrupt and has sold all its assets.
believing anything else is fantasy.
Opti
Tell me this ,The all an powerful OZ. Why hasn't the SEC added a Q after the ticker symbol if it's in Bankruptcy? That's the Law...
did you see the report filed with the SEC on Form 8-K. This report must contain a summary of the plan, but sometimes a copy of the complete plan is attached. It's still pending..
https://fintel.io/doc/sec-sgyp-synergy-pharmaceuticals-8k-2019-march-02-17959
I mention the application discharge hopefully the BK would follow,you took it one step further and said that I meant only the BK, oh well who knows what will happen this week.
Once the back and forth of issues of SGYP selling to Bausch is over and finalized, SGYP will very likely exit BK as pretty much a shell (in regards to traders/investors interest). After delisting, and the Q possibly removed in the coming months, they will then (If they still exist), most certainly have to seek institutional funding. Very interesting how this has, and is unfolding, along with how the stock has traded over the past few months!
Wait a minute! You swore the judge disapproved the BK. Why did you change your tune? What are we supposed to believe from you?
Opti
Bankruptcy is about to be Over. may convert to Chapter 7. OPTi Musk LOL..
https://budgeting.thenest.com/cancel-bankruptcy-after-its-filed-23238.html
they should have enough money from the sale to pay the bills..IJS
Things could change in the courts, but when you're as old as Stalin you're stuck in your way.LOL
And another doc# 489 scheduled hearing on Tuesday 03/12:
https://cases.primeclerk.com/Synergy/Home-DownloadPDF?id1=MTA3Mjk1Mw==&id2=0
Not sure if this means anything but doc 488 just came out and the US Trustee, Wm. Harrington is requesting the court to deny the approval of the disclosure statement in its current form. I would have to say he is giving them a hard time.
If you think these guys are fruitcakes, check out the series of posts beginning at 4140.
LOL
Opti
Is this the calm before the storm? I believe that this could take off anytime. The deal closes tomorrow.
Surely no one is fooled by his posts. What possibly could be his motivation? At least he has Abandoned his hysterical claims that the court rejected the BK.
Opti
That article is filled with old data
Investors Should Look Beyond Its Near-Term Weakness: Synergy Pharmaceuticals Inc. (SGYP)
https://nmsunews.com/2019/03/04/investors-should-look-beyond-its-near-term-weakness-synergy-pharmaceuticals-inc-sgyp/
Zero debt if the $200 million is allocated properly.
The sale of Synergy's assets, including all rights to TRULANCE® (plecanatide), dolcanatide and related intellectual property, is now expected to close on or about March 5, 2019 (DONE)
Could be a fresh start?.. time will tell..
Cautionary Information Regarding Trading in the Company’s Securities.
The Company’s securityholders are cautioned that trading in the Company’s securities during the pendency of the Chapter 11 Filings is highly speculative and poses substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by holders thereof in the Company’s Chapter 11 Filings. Accordingly, the Company urges extreme caution with respect to existing and future investments in its securities.
A plan of reorganization or liquidation may result in holders of the Company’s capital stock receiving no distribution on account of their interests and cancellation of their existing stock. If certain requirements of the Bankruptcy Code are met, a Chapter 11 plan can be confirmed notwithstanding its rejection by the Company’s equity securityholders and notwithstanding the fact that such equity securityholders do not receive or retain any property on account of their equity interests under the plan.
http://ih.advfn.com/stock-market/NASDAQ/synergy-pharmaceuticals-inc-SGYP/stock-news/79389997/current-report-filing-8-k
Opti
just giving you a hard time
Correct...just watching to see how it unfolds. As for your "babble" comment...I believe that's exactly what the board is for...discussions in regards to the stock. Thanks for being an Azz-hat.
.
My question exactly. No assets, nothing physical about it. That said I am curious if this thing goes up early day Monday. A lot of attention across all social media’s.
Forgot to mention....if this ticker gets any type of strong buying that comes in, it won't matter what's happening with the Company...shorts would be forced to cover. JMO
Going to be interesting to see what unfolds this coming week....
1. You've got Bausch approved to purchase substantially all SGYP's assets.
2. SGYP earnings are anticipated to be released the early part of this week.
3. The BK "Q" added Most likely end of this week and delisted in early April.
4. Short % back to 11% on Thursday and likely more on Friday... https://fintel.io/ss/us/sgyp
5. And a bunch of pissed off bagholders mixed with BK traders looking to play.
I almost forgot, as a former CFO now retired, is this all about NOL's plus other things not given up to the greedy ceo at Bausch?
like most people who have seen t;his whole thing materialize to its conclusion, there is one thing I am confused about. when I saw the action on Fri. after it was obvious the numb nuts who created this whole fiasco got their wish, I am trying to figure out who the hell is buying all those shares and why. according to most this is a done deal but the buying goes on amidst the selling. there is something about this whole thing that stinks.
When is this stock getting a "Q" added to the end?
Um, that is the transcript of the BHC conference call, not a SGYP conference call!
BHC could well have assets in the billions. SGYP no way no how not ever.
How could a company representative i.e Joe Papa inflate the numbers read it in the transcript...
https://finance.yahoo.com/news/bausch-health-companies-inc-bhc-220849010.html
BHC earnings call for the period ending December 31, 2018.
He is either intentionally trying to mislead people, dumber than rocks, or both.
Posted six times at the top of the board, yet we still have a deranged poster stating otherwise. What is it that motivates certain people?
Opti
SGYP News: Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
03/01/2019 06:30:00 PM
SGYP News: Current Report Filing (8-k)
02/27/2019 06:05:55 AM
SGYP News: Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
02/26/2019 06:04:00 PM
SGYP News: Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
02/26/2019 06:04:00 PM
SGYP News: Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets
02/26/2019 06:00:00 PM
News Alert: Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
Um - reread your own post. Assets were never in the billions.
You are looking at the numbers for two periods in a table, both of which are in the thousands, as a single number in the billions.
THat may be the goofiest valuation I have ever seen. Hope you did not buy based on that.
Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
NEW YORK, March 1, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today confirmed that the previously announced agreement with Bausch Health Companies Inc. has been approved by the Bankruptcy Court. The sale of Synergy's assets, including all rights to TRULANCE(R) (plecanatide), dolcanatide and related intellectual property, is now expected to close on or about March 5, 2019.
Synergy on December 12, 2018, initiated voluntary proceedings under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of New York to facilitate a sale and address its debt obligations. Additional information about Synergy's Chapter 11 cases can be found at https://cases.primeclerk.com/Synergy.
Synergy is advised in this transaction by Skadden, Arps, Slate, Meagher & Flom LLP, Sheppard, Mullin, Richter & Hampton LLP, Centerview Partners, FTI Consulting, and Togut, Segal & Segal LLP.
GREAT DD, IdeVos ,This should take off like a rocket soon..
P.S. assets were in the billions.Add 4 zeros
Institutional investors dumped shares just to jump back in Monday..
Hahahaha.. good one buddy..I can't wait to turn lemons into lemonade..
Bausch Health may strike a deal with $SGYP ..Hostile TakeOver would help with Valeant reputation, They can have my shares for PPS $4.00 LMAO ,JMO
If you're shorting this stock don't be shocked when you get the Margin Call ..Many institutional investors foresee a upswing in PPS..
https://monreport.com/2019/03/01/synergy-pharmaceuticals-inc-sgyp-will-keep-adding-cash-to-your-wallet/
Synergy Pharmaceuticals Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
That is ancient data. You need real time data. This world doesn’t stand still..
Blue sun, you may want to get out of the sun.. There is zero asset value in SGYP stock. You are trading air..
BK company, all assets sold. No offices. Will be delisted April 11. Current pps .049.
Opti
Many will regret selling after the smoke clears.. Too many analyst are pricing this stock above $2.00 ..Grab a seat and watch the finally..
An FDA approved drug that is actually decent and they go bankrupt? WTF? Was this the fault of management? WTF, went wrong with this company and who is to blame? I'd like more than just short quip for an answer.
Followers
|
116
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4273
|
Created
|
08/10/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |